case_images: PMC3891387_01
case_images: Endoscopic retrograde pancreatogram that was done at the first attack. It showed diffuse irregular narrowing of the main pancreatic duct.
case_images: kjim-20-163-g001.jpg
case_images: PMC3891387_01_kjim-20-163-g001.jpg
case_images: F1
case_images: An ERCP showed diffuse, irregular narrowing of the main pancreatic duct (Figure 1) and narrowing of the intrapancreatic common bile duct.
case_images: Endoscopic retrograde pancreatogram that was done 3 months after steroid treatment. Here the narrowing of the main pancreatic duct had been ameliorated by steroid treatment.
case_images: kjim-20-163-g002.jpg
case_images: PMC3891387_01_kjim-20-163-g002.jpg
case_images: F2
case_images: Three months after treatment with prednisolone (40 mg/day), a follow-up ERCP showed dramatic improvement of the narrowing (Figure 2) of both the main pancreatic duct and the common bile duct.
case_images: Endoscopic retrograde pancreatogram (arrows) that was done on relapse. It showed the segmental irregular narrowing of the main pancreatic duct in the tail portion.
case_images: kjim-20-163-g003.jpg
case_images: PMC3891387_01_kjim-20-163-g003.jpg
case_images: F3
case_images: The ERCP showed segmental irregular narrowing of the main pancreatic duct in the tail portion (Figure 3) and the narrowing of the intrapancreatic common bile duct.
case_images: Endoscopic retrograde pancreatogram that was done 3 months after re-treatment with high dose steroid. The segmental irregular narrowing of the main pancreatic duct in the tail portion was again improved.
case_images: kjim-20-163-g004.jpg
case_images: PMC3891387_01_kjim-20-163-g004.jpg
case_images: F4
case_images: A follow-up ERCP demonstrated obvious improvement for the narrowing of both the main pancreatic duct (Figure 4) and the common bile duct.